WINDTREE THERAPEUTICS INC /DE/ Long-term Debt and Lease Obligation
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Long-term Debt and Lease Obligation of $0 as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2015-03-16
- 2014-12-31: Long-term Debt and Lease Obligation $0.00.
- 2014-09-30: Long-term Debt and Lease Obligation $7.00K.
- 2014-06-30: Long-term Debt and Lease Obligation $28.00K.
- 2014-03-31: Long-term Debt and Lease Obligation $49.00K.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2014-09-30 | $7.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $28.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $49.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $69.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $89.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $109.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $129.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $148.00K 10-K · filed 2014-03-17 |
| 2012-09-30 | $167.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $186.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $205.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $224.00K 10-K · filed 2013-03-15 |
| 2011-09-30 | $242.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $260.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $301.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |